New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 17, 2014
11:05 EDTMEET, CACQ, VRSN, SIMG, IPXLHigh option volume stocks: SIMG CACQ IPXL VRSN MEET
News For SIMG;CACQ;IPXL;VRSN;MEET From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 25, 2015
07:32 EDTIPXLImpax granted EC marketing authorization for Numient
Impax announced that the European Commission has granted marketing authorization for Numient, a modified-release oral capsule formulation for the symptomatic treatment of adult patients with Parkinson's disease. The review of this application was conducted under the centralized licensing procedure as a therapeutic innovation, and is applicable in all 28 member states of the European Union, as well as Iceland, Liechtenstein and Norway. The EC decision is based on results from three Phase 3 controlled clinical studies which assessed the safety and efficacy of Numient in patients with early and advanced Parkinson's disease in the U.S. and in Europe.
06:04 EDTIPXLMylan and Perrigo set to face-off over potential targets, Bloomberg reports
Mylan (MYL) will likely find itself now competing with Perrigo (PRGO) for other assets, reports Bloomberg. According to Bloomberg Intelligence analyst Elizabeth Krutoholow, both companies may look to buy Impax Laboratories (IPXL), Stada Arzneimittel or Taro Pharmaceutical Industries (TARO). All of the potential targets are attractive due to their over-the-counter products. Reference Link
November 24, 2015
09:05 EDTIPXLImpax receives FDA approval for generic version of dutasteride capsules
Subscribe for More Information
08:54 EDTVRSNVeriSign says increased domain volume largely from China
VeriSign last night stated in a regulatory filing, "As noted on Verisign's third quarter earnings call on October 22, 2015, there was a higher volume of gross additions, during the third quarter, in international markets, particularly Asia. Verisign discloses the updated domain name base for the .com and .net registries at least daily on its website, This publicly available information reflects that this increased volume of domain name registrations has continued in October 2015 and in November 2015. As of November 22, 2015 Verisign's domain name base totaled 139.3 million, up 4.1 million from September 30, 2015. While there continues to be demand for domain names globally, the recent increased volume for Verisign's top level domains, as well as top level domains of other registries, during the fourth quarter is coming largely through registrars in China. In the past, Verisign has discussed many factors that affect the demand for domain names, including, but not limited to economic, social, and regulatory conditions, Internet adoption, Internet penetration, and increasing e-commerce. In addition to these factors affecting demand, Verisign is also evaluating additional potential factors unique to China that may also be responsible for the recent increased volume of new registrations in China. In no particular order, these potential factors, or combination of factors, could include, but may not be limited to, government initiatives in China to develop their online economy such as 'Internet Plus;' registry and registrar regulatory requirements; cultural influences such as the popularity of numeric domain names; increasing competition amongst Chinese registrars; potential increases in domain name investment activity; and recent capital markets volatility and access to capital in China. Verisign cannot predict if or how long this increased pace of gross additions will continue and we cannot at this time predict what the renewal rate for these domain names will be. Verisign has noted in the past that renewal rates for domain names registered in emerging markets, such as China, have historically been lower than those registered in more developed markets."
November 23, 2015
05:41 EDTVRSNVeriSign shares pricing in a lot of good news, says JPMorgan
JPMorgan analyst Sterling Auty says shares of VeriSign are pricing in a lot of good news after rallying 28% quarter-to-date. The recent surge in .com/.net names being registered is likely coming from domain name investors in China, which is not a consistent long-term source of growth, Auty tells investors in a research note titled ".Com Growth May Not Be Sustainable." He upped his price target for VeriSign shares to $84 from $74 and keeps an Underweight rating on the name.
November 17, 2015
11:17 EDTMEETMeetMe management to meet with JMP Securities
Meeting to be held in Boston on November 19 hosted by JMP Securities.
November 16, 2015
19:54 EDTMEETMeetMe management to meet with Northland
Subscribe for More Information
07:16 EDTIPXLHayman Capital gives quarterly update on stakes
NEW STAKES: Impax (IPXL), CF Industries (CF), GW Pharmaceuticals (GWPH), ProNAi Therapeutics (DNAI). INCREASED STAKES: BioMarin (BMRN), NMI Holdings (NMIH), Vertex (VRTX), Endo (ENDP). DECREASED STAKES: Mylan (MYL). LIQUIDATED STAKES: Perrigo (PRGO), Oasis Petroleum (OAS), Whiting Petroleum (WLL), Newfield Exploration (NFX), SM Energy (SM).

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use